GlassScriptPhysician profile
Jerry III Wisdom
NPI 1912570607
$5,706.05
in general payments reported to CMS, 2019-2025
44 companies · $1,622 in 2025
The $1,622 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $776 · 2022: $2,029 · 2023: $472 · 2024: $806 · 2025: $1,622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,900.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,384.77 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $751.61 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $531.74 | 2021-2025 | Jardiance, Ofev, Tradjenta |
| Regeneron Healthcare Solutions, INC. | $235.93 | 2021-2022 | |
| Lilly USA, LLC | $220.12 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $177.05 | 2022-2024 | |
| Amgen INC. | $173.81 | 2022-2025 | Evenity, Repatha |
| Nevro Corp. | $155.61 | 2022-2024 | Senza |
| Dexcom, INC. | $150.46 | 2025 | Dexcom G6 Transmitter |
| Actelion Pharmaceuticals US, INC. | $149.88 | 2021-2022 | |
| Globus Medical, INC. | $137.91 | 2025 | Senza |
| Grifols USA, LLC | $122.44 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.62 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $119.94 | 2022-2024 | Trintellix |
| Medtronic, INC. | $115.27 | 2025 | Symplicity G3, Interstim |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $114.80 | 2022 | |
| Tandem Diabetes Care, INC. | $112.09 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Gilead Sciences, INC. | $95.61 | 2021-2022 | |
| Corcept Therapeutics | $82.88 | 2023-2025 | Korlym |
| Jazz Pharmaceuticals INC. | $82.49 | 2021-2022 | |
| Sequel Med Tech, LLC | $62.66 | 2025 | Twiist |
| Mylan Specialty L.P. | $61.16 | 2022 | |
| Corium, LLC | $49.44 | 2023 | Azstarys |
| Novo Nordisk INC | $42.20 | 2024-2025 | Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.98 | 2022-2024 | Xifaxan, Trulance |
| Pfizer INC. | $38.97 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $35.62 | 2022-2023 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $33.94 | 2025 | |
| Biosense Webster, INC. | $30.19 | 2024 | Qdot Micro Catheter, Carto 3 |
| Merck Sharp & Dohme LLC | $26.43 | 2022 | |
| Ethicon INC. | $24.79 | 2022 | |
| Genzyme Corporation | $22.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.90 | 2022-2024 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $20.25 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.51 | 2023 | Nuedexta |
| Axsome Therapeutics, INC. | $19.08 | 2025 | Auvelity |
| Inspire Medical Systems, INC. | $18.71 | 2025 | Inspire |
| Tactile Systems Technology INC | $18.69 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.21 | 2022 | |
| Beta Bionics, INC. | $17.53 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Lundbeck LLC | $16.74 | 2024 | Rexulti |
| Exact Sciences Corporation | $13.80 | 2025 | The Cologuard Plus Collection Kit |
| Avanir Pharmaceuticals, INC. | $12.66 | 2022 | |
| Inogen, INC. | $4.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Wisdom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.